Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

Published:2011-03 Issue:3 Volume:52 Page:558-565
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Tremblay André J.,Lamarche Benoît,Lemelin Valéry,Hoos Lizbeth,Benjannet Suzanne,Seidah Nabil G.,Davis Jr. Harry R.,Couture Patrick

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference53 articles.

1. Coronary heart disease in seven countries;Circulation,1970

2. Epidemiology of coronary heart disease: the Framingham study;Castelli;Am. J. Med.,1984

3. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT);Stamler;JAMA.,1986

4. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations;Genest;Can. J. Cardiol.,2009

5. Serum plant sterols and their relation to cholesterol absorption;Tilvis;Am. J. Clin. Nutr.,1986

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment;Heliyon;2024-05

2. Association between pre-treatment with statin and its inhibitory effect on the onset of coronary artery disease at the time of coronary computed tomography angiography: a new look at an old medication;Heart and Vessels;2024-04-30

3. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14

4. Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial;Journal of Atherosclerosis and Thrombosis;2023-11-01

5. Adverse outcome pathway for pregnane X receptor-induced hypercholesterolemia;Archives of Toxicology;2023-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3